Norway's central bank increased its holdings in Asymchem Laboratories (06821) by 13,090 shares at a price of approximately 38.85 Hong Kong dollars per share.
The latest data from the Hong Kong Stock Exchange shows that on September 10, the Central Bank of Norway increased its holdings of Kerui Ying (06821) by 130,900 shares, with an average price per share of HK$38.8452, totaling approximately HK$5.0848 million.
According to the latest data from the Hong Kong Stock Exchange, on September 10, the Central Bank of Norway increased its holdings of Asymchem Laboratories (06821) by 130,900 shares, with an average price per share of HK$38.8452, for a total amount of approximately HK$5.0848 million. After the increase, the latest number of shares held is 1,697,100 shares, and the latest shareholding ratio is 6.16%.
Related Articles
Humanwell Healthcare (600079.SH): Injection of Fentanyl Hydrochloride has obtained market approval from the Federal Institute for Drugs and Medical Devices (BfArM) in Germany.
ZHIHU-W (02390) spent $302,100 to repurchase 279,700 shares on April 8th.
ES Services spent HK$371,800 to buy back 200,000 shares on April 9th.
Humanwell Healthcare (600079.SH): Injection of Fentanyl Hydrochloride has obtained market approval from the Federal Institute for Drugs and Medical Devices (BfArM) in Germany.
ZHIHU-W (02390) spent $302,100 to repurchase 279,700 shares on April 8th.
ES Services spent HK$371,800 to buy back 200,000 shares on April 9th.
